Categories
Tags
Authors
Archives
Categories:   All Categories
Suggested keywords
x

Glaucoma Clinical Trials: Awareness and Future Advancements

Glaucoma remains a leading cause of irreversible blindness worldwide, affecting millions of people and posing significant challenges for healthcare sy...

FDA issues Draft Guidance on the use of AI in Drug and Biological Product Development

The US Food and Drug Administration (FDA) recently provided a draft guidance on the application of artificial intelligence (AI) in regulatory decision...

Clinical Trials Trends in 2025: Pioneering Innovation and Overcoming Challenges

The clinical trials landscape in 2025 is shaped by technological advancements, regulatory shifts, and a growing demand for innovative therapies. In ou...
Top 10 Blogs of 2024
Navitas Life Sciences has been at the forefront, sharing knowledge and driving impactful discussions. Here’s a roundup of our top 10 blogs for 2024 that captivated readers and enriched the life sciences community. 1. The Impact of Generative AI in Clinical Trials Generative AI, a specialized branch of Artificial Intelligence (AI), offers tra...
Exploring AI and the Future of Regulatory Affairs with Navitas Life Sciences
In a recent episode of The Gens & Associates Podcast, host Steve Gens engaged in a compelling discussion with Navitas Life Sciences' leaders: Marty Boom, Global Head of Regulatory & Safety, and Tris Nockles, Labeling Networks Lead. The conversation explored Navitas' innovative "nets" framework, the integration of AI and automation in regula...
Navitas Life Sciences’ Thought Leadership Articles
As a leading CRO, Navitas Life Sciences consistently drives innovation in clinical trials, including oncology research, data sciences, regulatory affairs and pharmacovigilance. Our thought leaders have published a series of impactful articles that address critical industry challenges and advancements, showcasing our expertise and commitment to impr...
Strategic Resource Outsourcing in Medical Writing: Insights from the 2nd Roundtable
The second Medical Roundtable provided a rich platform for industry leaders to discuss strategies, innovations, and challenges in medical writing outsourcing. There were 11 attendees from across 8 companies, and the discussions emphasized the importance of strategic foresight, technological integration, and the optimal balance between insourcing an...
Data Governance in the Pharmaceutical Industry
In the pharmaceutical industry, where data drives innovation and ensures regulatory compliance, sound data governance practices are critical. This is because data is at the heart of the most recent innovative breakthroughs, like Artificial Intelligence (AI), Machine Learning (ML) and Data Science (DS). Without a high-quality, well understood datase...
Diversity, Equity, and Inclusion: An Imperative for Organizational Excellence
Diversity, equity, and inclusion (DEI) are no longer optional ideals for organizations. They are essential drivers of innovation, employee engagement, and sustainable growth. While many companies have made strides toward ensuring inclusive workplaces, the gap between intention and implementation remains significant. Addressing this gap requires not...
Global Clinical Trials: Navitas Life Sciences’ Strategic Edge in Thailand
Thailand’s pharmaceutical and clinical trials industry is undergoing a transformative phase, positioning itself as a critical player in the global healthcare ecosystem. As the demand for innovative solutions grows, regulatory complexities, market dynamics, and therapeutic advancements converge to create a challenging yet promising environmen...
Diabetes Clinical Trials: Breaking barriers in clinical research for advanced therapies
As a trusted diabetes CRO, we’re honoured to recognize World Diabetes Day and this year’s theme, 'Breaking Barriers and Bridging Gaps.' This theme calls on us to confront the critical challenges and inequalities that prevent effective diabetes care. Millions around the world struggle to access the healthcare, education, and resources ...
Real World Evidence Consulting for Smarter Clinical Trials
In a world where healthcare increasingly relies on data-driven insights, real-world evidence consulting (RWE) consulting is emerging as a pivotal tool, particularly in the pharmaceutical industry. RWE provides insights into the broader impact of medical interventions beyond the controlled environment of traditional clinical trials. Real world data ...
Managing Efficient Breast Cancer Clinical Trials to Drive Successful Outcomes
October is Breast Cancer Awareness Month, an annual campaign dedicated to raising awareness and reflecting on the progress in breast cancer research, prevention, and treatment. Breast cancer remains the most common cancer worldwide, with approximately 2.3 million new cases diagnosed each year. Advances in early detection and treatment are transform...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us